SINTX Technologies
Grant in 2023
SINTX Technologies, Inc. is a biomaterial company specializing in the research, development, manufacturing, and commercialization of medical implant products made from silicon nitride. Founded in 1996 and headquartered in Salt Lake City, Utah, SINTX offers a range of ceramic-based biomaterial solutions applicable in various medical and industrial fields. The company primarily focuses on producing spinal implant products, marketed under the Valeo brand, which are used in cervical and thoracolumbar surgeries. SINTX operates an ISO 13485 certified manufacturing facility and collaborates with external partners, providing custom manufacturing and development of silicon nitride ceramics for both medical and non-medical applications. Its products are recognized for their biocompatibility, bioactivity, and excellent bone affinity, and have been successfully implanted in patients across the United States, Europe, Brazil, and Taiwan.
Clene Nanomedicine
Grant in 2023
Clene Nanomedicine, established in 2012 and headquartered in Salt Lake City, Utah, is a clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics for neurodegenerative diseases. The company has pioneered a unique nanotechnology drug platform that enables the creation of orally-administered neurotherapeutic drugs. This technology, known as Clean-Surface Nanosuspension, produces clean-surface nanocrystal medicines and serves as a foundation for a pipeline of new drug candidates aimed at addressing various diseases with significant unmet medical needs. Clene Nanomedicine's primary focus areas include demyelinating disorders and oncology.
University of Utah
Grant in 2023
The University of Utah, located in Salt Lake City, is the state's leading public university and the sole institution in Utah offering a medical school. It provides a diverse range of academic programs, featuring over 100 undergraduate majors in fields such as business, engineering, and health careers, as well as more than 90 graduate degrees. In addition to its medical school, the university also includes schools of law and pharmacy. The University of Utah promotes an active student life, hosting over 400 clubs and organizations, alongside recreational programs and cultural events. Admission to the undergraduate programs requires an application, along with academic transcripts and standardized test scores, with a minimum GPA of 2.6 and typical ACT/SAT scores around 18 and 860, respectively. Financial aid is available based on need, and students are encouraged to complete the FAFSA to determine their eligibility for various forms of assistance, including scholarships and loans.
University of Utah
Grant in 2023
The University of Utah, located in Salt Lake City, is the state's leading public university and the sole institution in Utah offering a medical school. It provides a diverse range of academic programs, featuring over 100 undergraduate majors in fields such as business, engineering, and health careers, as well as more than 90 graduate degrees. In addition to its medical school, the university also includes schools of law and pharmacy. The University of Utah promotes an active student life, hosting over 400 clubs and organizations, alongside recreational programs and cultural events. Admission to the undergraduate programs requires an application, along with academic transcripts and standardized test scores, with a minimum GPA of 2.6 and typical ACT/SAT scores around 18 and 860, respectively. Financial aid is available based on need, and students are encouraged to complete the FAFSA to determine their eligibility for various forms of assistance, including scholarships and loans.
Domus Diagnostics
Grant in 2023
Domus Diagnostics, founded in 2021 and based in Park City, Utah, specializes in care diagnostics focused on respiratory disease home testing services. The company develops affordable diagnostic devices that facilitate everyday testing for infectious diseases. These devices are also designed to assist governments and institutions in conducting extensive testing during new infectious disease outbreaks. By enabling early treatment, Domus Diagnostics aims to prevent the escalation of diseases into pandemic situations.
Peel Therapeutics
Grant in 2018
PEEL Therapeutics, Inc. is a clinical-stage biotechnology company based in Salt Lake City, Utah, that focuses on developing cancer-fighting therapeutics derived from proteins found in elephants. Incorporated in 2015, the company utilizes its proprietary platform to create anti-cancer protein nanoparticles, specifically elephant p53 (EP53), which are designed to regulate cellular responses to environmental stresses. This approach aims to stimulate gene transcription related to cell cycle arrest, apoptosis, and metabolism, thereby enhancing the treatment and potential cure for cancer and inflammatory diseases. In addition to its primary focus on cancer therapeutics, PEEL Therapeutics is exploring new drug candidates that leverage natural biological mechanisms to address various health challenges.
Owlet Baby Care
Series B in 2016
Owlet Baby Care Inc. specializes in developing and manufacturing innovative monitoring solutions for infants, focusing on providing parents with real-time insights into their child's health. Founded in 2012 and based in Lehi, Utah, the company offers a range of products, including the Owlet Smart Sock, which tracks an infant's heart rate and oxygen levels while sleeping, alerting parents to any concerns. Additionally, the Owlet Cam allows parents to monitor their baby through their smartphones with high-definition clarity. The Owlet Monitor Duo combines the functionalities of the Smart Sock and the Cam for comprehensive monitoring. The company also provides the Owlet Dream Lab, an interactive program aimed at helping parents establish healthy sleep habits for their infants. Owlet's products are available for purchase online, ensuring accessibility for parents seeking peace of mind regarding their child's well-being.
Recursion Pharmaceuticals
Grant in 2015
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company based in Salt Lake City, Utah, that focuses on revolutionizing drug discovery through the integration of advanced technologies such as artificial intelligence, automation, and bioinformatics. Founded in 2013, the company has developed a comprehensive drug discovery platform that includes various tools and software, such as ReChem for chemical compound design, ReScreen for managing complex experimental workflows, and RePredict for modeling drug relationships using machine learning. These innovations enable Recursion to generate extensive biological and chemical datasets, facilitating the exploration of foundational biology and accelerating the development of new therapeutic solutions. Through its unique approach, Recursion aims to significantly enhance patient outcomes and streamline the drug discovery process.
AquaMost, Inc. is a Madison, Wisconsin-based company specializing in chemical-free water treatment solutions. Its flagship product, the SX Reactor, employs a combination of onsite generation of chlorine, hydroxyl radicals, and ultraviolet irradiation to effectively eliminate bacteria from various water sources, achieving a kill rate of over 99%. This patented technology is particularly beneficial for the oil and gas industry, where it helps treat flowback and produced water, as well as in other sectors such as food and beverage, dairy, and drinking water treatment. AquaMost provides comprehensive services, including delivery, setup, and maintenance of its systems, which have been deployed in regions like Texas, Colorado, Utah, and Canada. Established in 2006, the company focuses on delivering innovative water purification solutions without the use of chemicals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.